What's Old Is New: Former Commissioners and the Future of FDA
This article was originally published in RPM Report
Four ex-commissioners outline their ideas for reforming the Food & Drug Administration. They don't think new ideas are necessary: just follow through on their old favorites.
You may also be interested in...
Donald Kennedy has passed away after contracting COVID-19 in a nursing home. Even 40 years after he ran FDA, a remarkable number of themes of his tenure still resonate.
The Reagan-Udall Foundation is an early priority for FDA in implementing the landmark legislation enacted by Congress in 2007. It is also a lightning road for criticism from Congress about the agency's relationship with regulated industry. We asked foundation chairman Mark McClellan for a status report.
Everyone agrees FDA needs more money to do its job. Its not getting it. Does that mean the drug safety law will just end up making a bad situation worse?